From start to finish, from cells to drugs, your research depends on the starting material’s quality.
Biological therapeutics largely depends on the use of human-based models early in the drug discovery process. Access to a diverse population of donors, well established and consistent protocols for the collection and preparation of human cells, and validation of the integrity of the cells maximize the efficiency and accuracy of the studies, especially analysis of gene and protein expression, and enhances the success of reaching the marketplace.
Donor accessibility and characterization and the quality of cells are unquestionably key to the successful development of new biological therapeutics for the treatment of a disease. With our strategically placed CGT Clinics, our donor pool is one of the largest HLA-typed and most characterized in the industry, allowing readily available donors that suit your drug discovery and development criteria. Each of our CGT Clinics houses an on-site state-of-the-art laboratory, providing an end-to-end service whereby cells are processed, isolated, and cryopreserved or shipped out fresh immediately after collection from a donor. Procedures and protocols involved in cell collection, processing, isolation, and analysis follow strict guidelines and quality standards, ensuring consistent, compliant, viable, and pure cells with guaranteed counts.
Our new GMP-compliant Leukopaks meet regulatory requirements for use in allogeneic cell-based therapies. Our state of the art facility and strict standard operating procedures ensure a clean environment and the highest quality of cell possible. Our products have been tested by the University of California, San Francisco, and are pending further audits from academic and federal agencies.
The Right Donor
We are the only company in the industry with multiple CGT Clinics strategically positioned throughout the United States. These locations add donors of diverse demographics and backgrounds, allowing ease in selecting a specific donor for your research.
Our tissue collection, cell processing, cell isolation, and cell analysis methods are conducted using approved standard operating procedures (SOPs) performed by qualified personnel in accordance with cGMP guidelines and with strict quality assurance (QA) oversight and review.
We provide an end-to-end service whereby cells are collected, processed, isolated, and cryopreserved or shipped out fresh immediately after collection from one of our CGT Clinics. This end-to-end service provides the ability to customize each step of the procedure by allowing you to get the exact product for your research.
Whether you are requesting tissue or primary cells, fresh or frozen, our staff works with you to schedule a day for a collection that suits your schedule. For fresh whole blood, bone marrow, Leukopaks, and primary cells with no donor requirements, we can fulfill collection and isolation within 3 days upon receipt of your purchase order. Additionally, we offer a variety of delivery options, including same day delivery, depending on your location.